Standard pre‑examination protocol – must be demonstrated:
Action: Introduce yourself, explain the examination, and obtain verbal consent.
Key observations:
Anthropometry:
Systematic examination:
Assess:
📋 Case Presentation – (fill in during exam)
This is a _____-year-old _____ child, referred for _____ (obesity / weight gain). On examination, height _____ percentile, BMI _____ percentile, waist‑to‑height ratio _____. General exam: _____ (acanthosis nigricans, striae, dysmorphic features, genitalia). Developmental: _____ (appropriate/delayed). Associated signs: _____.
Exogenous (Simple) Obesity
• Most common – calorie excess, sedentary lifestyle.
Endocrine Causes
• Cushing's syndrome (short, truncal obesity, striae)
• Hypothyroidism (short, goitre, dry skin, delayed reflexes)
• Growth hormone deficiency (short, cherubic facies)
• Pseudohypoparathyroidism (short, round face, short 4th metacarpal)
• Insulin resistance / T2DM (acanthosis nigricans)
Syndromic Causes
• Prader‑Willi (hypotonia, hyperphagia, small hands/feet, hypogonadism)
• Bardet‑Biedl (obesity, retinitis pigmentosa, polydactyly, renal anomalies)
• Alström (obesity, deafness, retinitis pigmentosa, T2DM)
• Down syndrome (short, dysmorphic, hypotonia)
• Klinefelter (tall, gynecomastia, hypogonadism)
• Lawrence‑Moon‑Biedl
Drug‑Induced
• Corticosteroids, antipsychotics (olanzapine, risperidone)
• Thyroid function – TSH, free T4 (exclude hypothyroidism).
• Fasting glucose, HbA1c – screen for T2DM.
• Lipid profile – dyslipidaemia (common).
• Liver function – ALT, AST (fatty liver).
• IGF‑1 / GH stimulation – if growth hormone deficiency suspected.
• Cortisol, dexamethasone suppression – if Cushing's suspected.
• Karyotype – if syndromic (Turner, Klinefelter).
• Genetic testing – if Prader‑Willi (methylation analysis), Bardet‑Biedl.
• Genetic testing – Prader‑Willi (15q11.2‑13), Bardet‑Biedl (BBS genes).
• MRI brain – if hypopituitarism / Cushing's (pituitary adenoma).
• Pelvic ultrasound – if PCOS suspected.
• Sleep study – if obstructive sleep apnoea suspected.
• Thyroid function – exclude hypothyroidism.
• Cortisol – exclude Cushing's.
• Glucose, HbA1c – exclude T2DM.
• Lipids – screen for dyslipidaemia.
• Liver function – screen for fatty liver.
• Blood pressure – hypertension.
• Lipid profile – dyslipidaemia.
• HbA1c / OGTT – T2DM.
• Liver ultrasound – fatty liver / steatohepatitis.
• Sleep study – if sleep apnoea suspected.
• Orthopaedic – if Blount's disease or SCFE suspected (X‑ray).
🔹 Management – Across Organ Systems
Dietary modification (healthy eating, portion control), physical activity (60 min/day), behavioural therapy.
Metformin (if insulin resistance / T2DM), liraglutide (if ≥12 years, BMI >95th). Orlistat (limited use in children).
Thyroxine (hypothyroidism), hydrocortisone (adrenal insufficiency), GH (GH deficiency).
Bariatric surgery (if severe obesity with comorbidities, and failed medical therapy – limited use).
Counselling, family‑based intervention, address bullying / self‑esteem.
T2DM – metformin / insulin. Dyslipidaemia – statin (if >10 years). Sleep apnoea – CPAP. Blount's disease – orthopaedic referral.
Monitor BMI, BP, lipids, HbA1c; screen for T2DM every 1‑2 years.
If syndromic – recurrence risk.
📈 Prognosis
📋 Follow‑up Schedule